Skip to main content
Log in

Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: Relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In order to clarify the complex interrelationship between serum calcium, 1,25-dihydroxyvitamin D (1,25(OH)2D), and parathyroid hormone (PTH), and the urinary excretion of cyclic AMP (cAMP) in response to exogenous PTH in pseudohypoparathyroidism (PHP) and related diseases, we investigated 3 patients with parathyroid disorders before and after treatment with 1α-hydroxyvitamin D3 (1α-OH-D3).

Low plasma 1,25(OH)2D before treatment increased after giving 1α-OH-D3 (0.1 μg/kg/day), where-as high plasma PTH measured by the C-terminal assay (C-PTH) decreased in all 3. No response in urinary cAMP was found before or after treatment in 2 patients with PHP type I, despite the fall of plasma C-PTH. However, in one patient with extremely high plasma C-PTH but normal N-PTH (measured by a homologous radioimmunoassay using 1–34 human PTH), urinary cAMP response to exogenous PTH was increased after treatment with 1α-OH-D3. We suggest that he had pseudopseudohypoparathyroidism (PPHP) with Albright's hereditary osteodystrophy and a partial deficiency of renal 1α-hydroxylase. In this patient secondary hyperparathyroidism is thought to be due to 1,25(OH)2D deficiency, and the decreased responsiveness to exogenous PTH before treatment due to excess PTH occupying renal receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balachandar V (1975) Pseudohypoparathyroidism with normal serum calcium level. Am J Dis Child 129:1092–1095

    Google Scholar 

  2. Dokoh S (1978) Competitive protein binding assay for 1,25-dihydroxyvitamin D in human plasma. Endocrinol Jap 25:431–436

    Google Scholar 

  3. Drezner MK (1976) 1,25-dihydroxycholecalciferol deficiency: The probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab 42:621–628

    Google Scholar 

  4. Fukase M (1979) Cholecalciferol suppression of PTH secretion from monolayer culture of human parathyroid carcinoma cells. Fourth Workshop on vitamin D, Berlin, p 61 (Abstract)

  5. Forte LR (1976) Renal adenyl cyclose and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3′,5′-monophosphate excretion. J Clin Invest 57:559–568

    Google Scholar 

  6. Fukushima M (1975) Metabolism of 1α-hydroxyvitamin D3 in perfused rat liver. Biochem Biophys Res Comm 66: 632–638

    Google Scholar 

  7. Haussler MR (1976) The assay of 1α,25-dihydroxyvitamin D3: Physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol 5:151S-165S

    Google Scholar 

  8. Honma M (1977) An ultrasensitive method for the simultaneous determination of cyclic AMP and GMP in small-volume samples from blood and tissue. Biochem Med 18:257–273

    Google Scholar 

  9. Kind HP (1973) Latent pseudohypoparathyroidism: A clue to the pathogenesis of end-organ refractoriness to parathyroid hormone. Clin Res 21:1059 (Abstract)

    Google Scholar 

  10. Kind HP (1973) A classification of the hypoparathyroid syndrome based on the PTH response test. Pediatr Res 7: 324 (Abstract)

    Google Scholar 

  11. Monn E (1976) Pseudohypoparathyroidism. A difficult diagnosis in early childhood. Acta Paediatr Scand 65:487–493

    Google Scholar 

  12. Nusynowitz ML (1976) The spectrum of the hypoparathyroid states. Medicine 55:105–119

    Google Scholar 

  13. Rodriguez HJ (1974) Pseudohypoparathyroidism type II: Restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab 39:693–701

    Google Scholar 

  14. Seino Y (1978) The plasma levels of 25-hydroxyvitamin D in patients with various liver diseases and the response of 25-hydroxyvitamin D to vitamin D treatment. Acta Paediatr Scand 67:39–42

    Google Scholar 

  15. Seino Y (1980) Treatment of hypophosphatemic vitamin D resistant rickets with massive dose of 1α-hydroxyvitamin D3 during childhood. Arch Dis Child 55:49–53

    Google Scholar 

  16. Seino Y (1980) Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants and children. Calcif Tiss Int 30:1–3

    Google Scholar 

  17. Seino Y Idiopathic hypoparathyroidism with Albright's hereditary osteodystrophy (in preparation)

  18. Shimotsuji T (1976) A competitive protein binding assay for plasma 25-hydroxyvitamin D3 in normal children. Tohoku J Exp Med 118:233–240

    Google Scholar 

  19. Stögmann W (1975) Pseudohypoparathyroidism: Disappearance of the resistance to parathyroid extract during treatment with vitamin D. Am J Med 59:140–144

    Google Scholar 

  20. Werder EA (1978) Pseudohypoparathyroidism and idiopathic hypoparathyroidism: Relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3′,5′-monophosphate response to parathyroid extract. J Clin Endocrinol Metab 46:872–879

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seino, Y., Ishida, M., Yamaoka, K. et al. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: Relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH. Eur J Pediatr 135, 267–271 (1981). https://doi.org/10.1007/BF00442101

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442101

Key words

Navigation